Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

SELL
$20.5 - $37.33 $141,347 - $257,390
-6,895 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$35.68 - $56.27 $246,013 - $387,981
6,895 New
6,895 $266,000

Others Institutions Holding CLDX

About Celldex Therapeutics, Inc.


  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.3B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Ntb Financial Corp Portfolio

Follow Ntb Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ntb Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Ntb Financial Corp with notifications on news.